Scientific method

Satellogic Signs Letter of Intent with Mexico’s Space Agency for Dedicated Satellite Earth Observation Program

Retrieved on: 
Tuesday, December 13, 2022

Satellogic will host a team of AEM executives and experts at its Pilot Plant in Montevideo, Uruguay, for a facility tour early next year.

Key Points: 
  • Satellogic will host a team of AEM executives and experts at its Pilot Plant in Montevideo, Uruguay, for a facility tour early next year.
  • Satellogic recently signed a three-year program agreement with the Republic of Albania, which includes training of remote-sensing specialists to bolster Albanias domestic workforce.
  • This solution is one of the many ways Satellogic is working to remove barriers and increase access to EO technology and data.
  • Using its patented Earth imaging technology, Satellogic unlocks the power of EO to deliver high-quality, planetary insights at the lowest cost in the industry.

Reduced-risk* Potential of Velo as Cigarette Alternative Reinforced by Innovative Real-world Study

Retrieved on: 
Tuesday, December 13, 2022

The study provides important new data and insights into the real-world health impact in Velo consumers compared to smokers, former smokers and never smokers.

Key Points: 
  • The study provides important new data and insights into the real-world health impact in Velo consumers compared to smokers, former smokers and never smokers.
  • We have already generated data that shows Velo has a toxicant profile better than snus and comparable to Nicotine Replacement Therapy (NRT)iii.
  • These results add further evidence that supports the important contribution Velo can make to Tobacco Harm Reduction.
  • The study included participants who had been using Velo exclusively for over six months, as well as current smokers, former smokers and never smokers.

Numinus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training Research

Retrieved on: 
Thursday, December 8, 2022

Clinical trial dosing will use Numinus Bioscience's Psilocybin Tea, EnfiniTea one of the first Phase 1 clinical trials that will report on whole Psilocybe mushroom safety.

Key Points: 
  • Clinical trial dosing will use Numinus Bioscience's Psilocybin Tea, EnfiniTea one of the first Phase 1 clinical trials that will report on whole Psilocybe mushroom safety.
  • Additionally, the clinical trial will use Numinus Bioscience's EnfiniTea, a whole mushroom Psilocybe tea product, for trial dosing.
  • "We're proud to offer one of the first training programs with the option to participate in an experiential clinical trial for practitioners looking to expand their psychedelic-assisted therapy education," said Paul Thielking, Chief Science Officer, Numinus.
  • Numinus expects the clinical trial may be expanded to include additional Numinus clinic locations in the future.

To Develop Japan's First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research

Retrieved on: 
Tuesday, November 22, 2022

This joint study will attempt to develop Japan's first diagnostic workflow for mild cognitive impairment (MCI) and Alzheimer's disease (AD) that uses blood biomarkers.

Key Points: 
  • This joint study will attempt to develop Japan's first diagnostic workflow for mild cognitive impairment (MCI) and Alzheimer's disease (AD) that uses blood biomarkers.
  • Usuki City Medical Association will recruit applicants (50 years and older) who wish to participate in the study.
  • Primary care physicians affiliated with Usuki City Medical Association will perform simple cognitive function tests on applicants and select around 200 people with suspected MCI or mild dementia.
  • With this joint research, the four parties aim to establish a new diagnostic workflow for Alzheimer's disease that is based on blood biomarkers and includes primary care physicians.

Signing of a Large Contract With an Industry Leader for Kalray's DPU Processor

Retrieved on: 
Monday, November 14, 2022

ric Baissus, Kalray CEO, says : The signing of this contract is a major milestone for Kalray.

Key Points: 
  • ric Baissus, Kalray CEO, says : The signing of this contract is a major milestone for Kalray.
  • The contract covers the development and supply of acceleration cards based on Kalray's DPU processors, on which the customer intends to build the next generation of its products and services.
  • The signing of this contract demonstrates Kalray's ability to win over the most demanding players in the market and to sign contracts with very high revenue-generating potential.
  • Kalray's ability to support such a large contract comes from its "fabless" business model.

ABARCA PRIZE RECOGNIZES MEDICAL-SCIENTIFIC RESEARCH IN ITS 2ND EDITION, BY HM HOSPITALES

Retrieved on: 
Friday, October 28, 2022

The 'ABARCA PRIZE' award ceremony held in Madrid (Spain) brought together more than 130 guests and renowned public figures.

Key Points: 
  • The 'ABARCA PRIZE' award ceremony held in Madrid (Spain) brought together more than 130 guests and renowned public figures.
  • The ABARCA PRIZE is endowed with 100,000 euros and an accrediting diploma.
  • Professor Sansonetti said "It is an honor to be awarded the ABARCA PRIZE.
  • The 'ABARCA PRIZE' Award began in 2021 to highlight on the international stage the impact of medical-scientific advances and innovations.

Delic Labs President and CSO Dr. Markus Roggen to Discuss the Importance of R&D for Business Growth at MJBizCon

Retrieved on: 
Thursday, October 27, 2022

With over 1,400 exhibitors, 35,000 attendees and countless networking opportunities, MJBizCon is the world's premier cannabis business conference and tradeshow.

Key Points: 
  • With over 1,400 exhibitors, 35,000 attendees and countless networking opportunities, MJBizCon is the world's premier cannabis business conference and tradeshow.
  • At this year's conference, Dr. Markus Roggen will participate in MJBizScience Symposium's panel discussion entitled, R&D As a Business Tool: Maximizing Revenue by Focusing on The Scientific Method.
  • Alongside leading professionals within the cannabis industry, Roggen will highlight the foundational importance of research and development and explain how good science can help a company's bottom line.
  • Delic Labs is a federally licensed cannabis and psilocybin research laboratory focused on extraction optimization, analytical testing, and process development.

Data Silicon Awards: Kalray Wins Gold Innovation Award, Public Award and Bronze Grand Prize With Its New Generation DPU Processor

Retrieved on: 
Wednesday, October 26, 2022

Organized as part of the Silicon Day Data, the Silicon Data Awards recognize the best data projects, solutions and innovations in the IT and tech world.

Key Points: 
  • Organized as part of the Silicon Day Data, the Silicon Data Awards recognize the best data projects, solutions and innovations in the IT and tech world.
  • These awards once again recognize Kalrays unique technology, which also won an award at the Flash Memory Summit last August.
  • With its patented 80-core architecture, Kalray's DPU processor manages multiple data streams in parallel and without bottlenecks.
  • Kalrays DPU is a low-power, high-performance programmable processor dedicated to data-intensive applications for fast-growing markets such as the data center, AI, edge computing, 5G, automotive ...

Research supported by Royal Commission for AlUla provides new insights into huge, ancient animal traps known as 'kites'

Retrieved on: 
Monday, October 24, 2022

Dr Remy Crassard, a leading expert on desert kites, notes that they are some of the largest ancient structures of their era.

Key Points: 
  • Dr Remy Crassard, a leading expert on desert kites, notes that they are some of the largest ancient structures of their era.
  • Kites may have led to hunting well beyond subsistence levels, related to "an increase in symbolic behaviour related to food production and social organisation".
  • That hub, the Kingdoms Institute, is currently active as a research organization, with plans to open a physical presence at AlUla by 2030.
  • The RCU-sponsored research in and around AlUla is adding to the knowledge base that will inform the Kingdoms Institute.

2CRSi SA: 2CRSi, Clever Cloud, Kalray and Vates join forces for Sovereign and Innovative Data Center Equipment

Retrieved on: 
Saturday, October 22, 2022

New classes of equipment are needed based on new hardware and software foundations to provide more efficient, power-optimized, and more open data center infrastructures.

Key Points: 
  • New classes of equipment are needed based on new hardware and software foundations to provide more efficient, power-optimized, and more open data center infrastructures.
  • The ReNESENS project is bringing together some of the most advanced French companies with unique expertise in the new class of DPU data processors, virtualization software, highly efficient servers and innovative data center architecture; Vates, Clever Cloud, Kalray and 2CRSi.
  • The project intends to develop an innovative and attractive sovereign proposition, for both end users and the ecosystem of data center players.
  • Clever Cloud will bring all its expertise to this initiative and to its partners 2CRSi, Kalray and Vates.